Elizabeth C. Moore, M.S.
Ms. Moore has over 25 years of experience in strategic regulatory registration and product development; management of FDA and global health authority interactions; and completion of regulatory and other due diligence for acquisition targets. She started her career at the National Institutes of Health (NIH) with posts at both the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. Following her tenure at the NIH, Ms. Moore joined Agouron Pharmaceuticals as Director, Regulatory Affairs for Oncology Development. Subsequent to the Pfizer-Warner Lambert acquisition of Agouron, she was appointed Regulatory Affairs Site Head (Senior Director) of Pfizer Global R&D in La Jolla, CA. For the last 15 years, Ms. Moore has directed global regulatory affairs strategy and operations for both public and private companies, holding senior-level positions at Coronado Biosciences (now Fortress), Paramount BioSciences, Tracon Pharmaceuticals, Salmedix (acquired by Cephalon), and most recently, Fate Therapeutics. Ms. Moore received her B.S. in Pharmacy from the University of Georgia and M.S. in Administrative Science from the Johns Hopkins University.